CTRI/2022/01/039691
Not Yet Recruiting
N/A
A CLINICAL PROSPECTIVE OBSERVATIONAL STUDY TOEVALUATE THE EFFECTIVENESS OF INDIVIDULISEDHOMOEOPATHIC MEDICINE IN DIABETES MELLITUS 2
SUNIL THUMAR0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Sponsor
- SUNIL THUMAR
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 A diagnosed or first time diagnose case of DM 2 with blood investigation according to diagnostic test and including Symptomatic and Asymptomatic category.
- •2 In these Cases patients of any age and both sexes are included.
- •3 All type of socio\-economic status patients.
Exclusion Criteria
- •1 Critical patient who have acute metabolic complication with known case of DM 2\.
- •2 Patients with serious cardiac disorder, asthma or its previous history and other terminal illness.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Prospective observational study evaluating clinical significance of serial quantification of PCT in respiratory diseasesRespiratory diseasesJPRN-UMIN000012727Respiratory Medicine Division, Fukujuji Hospital500
Completed
N/A
A Prospective Observational Study of clinical use of Imeglimin for type 2 diabetes mellitusJPRN-UMIN000046316Kyoto University Hospital Department of Diabetes, Endocrinology, and Nutrition30
Not Yet Recruiting
N/A
To Study Clinical Characteristics, Treatment Outcome of Coronavirus (COVID-19) PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/05/025247Dr Amit Patel
Not Yet Recruiting
N/A
Trial to study findings in skin changes due to leprosy, remaining after completion of treatment in leprosy patientsCTRI/2020/11/028927none
Completed
N/A
A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agoniststype 2 diabetesJPRN-UMIN000048407Kanto Rosai Hospital65